CHRISTINA DISHMOND: Open Payments
NPI 1487262762 · CORNELIUS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 99 payments from 21 companies in 2025. Trend: 2023 $766 · 2024 $1,247 · 2025 $2,076
Food & beverage: $1,990Education: $85
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $346 |
| AstraZeneca Pharmaceuticals LP | 8 | $310 |
| Novartis Pharmaceuticals Corporation | 14 | $229 |
| GlaxoSmithKline, LLC. | 18 | $227 |
| CSL Behring | 9 | $222 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $158 |
| ABBVIE INC. | 5 | $102 |
| Incyte Corporation | 4 | $98 |
| GENZYME CORPORATION | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
Products named: DUPIXENT, FASENRA, NEFFY, TRELEGY ELLIPTA, Hizentra, XOLAIR, RINVOQ, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
